Cardiff Oncology, Inc. (FRA:XE7C)
Germany
· Delayed Price · Currency is EUR 1.750
+0.076 (4.54%)
At close: Dec 4, 2025
Cardiff Oncology Revenue
Cardiff Oncology had revenue of $120.00K USD in the quarter ending September 30, 2025, a decrease of -27.27%. This brings the company's revenue in the last twelve months to $501.00K, down -27.18% year-over-year. In the year 2024, Cardiff Oncology had annual revenue of $683.00K with 39.96% growth.
Revenue (ttm)
$501.00K
Revenue Growth
-27.18%
P/S Ratio
286.12
Revenue / Employee
$15.18K
Employees
33
Market Cap
122.18M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 683.00K | 195.00K | 39.96% |
| Dec 31, 2023 | 488.00K | 102.00K | 26.42% |
| Dec 31, 2022 | 386.00K | 27.00K | 7.52% |
| Dec 31, 2021 | 359.00K | -7.00K | -1.91% |
| Dec 31, 2020 | 366.00K | 121.37K | 49.61% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |